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ABSTRACT: pH-sensitive linkers designed to undergo
selective hydrolysis at acidic pH compared to physiological
pH can be used for selective release of therapeutics selectively
at targets and orthoesters have been demonstrated to be good
candidates for such linkers. Following an HPLC screening, a
Spiro Diorthoester (SpiDo) derivative was identiﬁed as a
potent acid-labile group for the development of pH-sensitive
targeted systems. After incorporation of this linker into
activatable FRET-based probe and side-by-side comparison
to a well-known alkylhydrazone linker, this SpiDo linker has
shown a fast and pH sensitive hydrolysis for mild acidic
conditions, a pH sensitive lysosomal hydrolysis, and high
stability in human plasma.
■ INTRODUCTION
In cancer therapy, many successful strategies to increase the
therapeutic index of highly cytotoxic drug involve prodrugs that
release the active drug once it has reached its target.1 Such an
approach relies on the ability of a linker to be cleaved in
response to physiological, pathological, or pathochemical
conditions (e.g., enzyme overexpression, redox microenviron-
ment, and pH gradient).2,3 Acidic pH-gradients have been
extensively used as biological stimuli to trigger the release of
delivery systems and, as a result of many studies, several acid-
labile structures have been reported over time in the design of
drug delivery systems, via protonation mechanisms such as pH
dependent microcapsules4 or bond breaking mechanisms in
polymers5 and molecular entities (e.g., acylhydrazone,6−9
acetal,10 silyl ether,11,12 cis-aconityl,13 β-thiopropionate,14,15
thiomaleamic,16 and imidazole17,18 derivatives). These chemical
groups have been used for both intra- and extracellular drug
release. Upon cellular internalization, a delivery system
undergoes passage through acidic endosomal/lysosomal
compartments, at pH 6−6.8 and 4.5−5.5, respectively, cleaving
the labile linker and releasing the drug payload.19 Alternatively,
the extracellular hypoxic tumor microenvironment is reported
to be 0.5−1 pH unit more acidic than healthy tissue and blood.
Most of the industrial approaches for antibody−drug
conjugates (ADC) encompassed the use of hydrazone linkers
which have been used to facilitate the release of a highly toxic
payload after ADC internalization (Mylotarg and Inotuzumab
ozogamicin).20 However, both Myoltarg and Inotuzumab
ozogamicin have been withdrawn from the market and phase
III clinical trial. The withdrawal of Mylotarg was attributed to
toxicities related to acylhydrazone linker instability, which
resulted in an increased number of treatment-related mortal-
ities.21 In the course of bridging the gap between shielding
normal tissue from toxic compounds and delivering drugs at
therapeutic concentrations to target cells, we have explored the
use of a Spiro Diorthoester (SpiDo) for lysosomal release.
Heller22−28 and Szoka29−32 have already prepared a series of
polymers based on the diorthoester moiety and exploited their
pH-sensitive properties to develop sustained drug release
systems. Of particular importance, the half-life of liposomal
formulations of Spiro Diorthoester were reported by Szoka and
Guo29,30 to be approximately 2.5 h at pH 6, and in vivo
experiments showed that the lipid derivatives can be used to
further modify the delivery properties of the lipidic delivery
system in order to enable prolonged circulation time. (e.g., by
changing the lipid chain and the polar head). All of these
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literature reports revealed the high potency of orthoesters in
the ﬁeld of bioresponsive polymers and acid-labile liposomes.
However, to the best of our knowledge, the precise behavior of
the Spiro Diorthoester in response to speciﬁc biological stimuli
and in the response induced by lysosomal uptake has not been
reported on its own. Consequently, its potency to be used as a
cleavable linker in targeted systems such as ADCs, which
requires both long plasma stability and fast lysosomal cleavage,
has not yet been clearly established. The aim of this study is to
establish and demonstrate this potency by comparing with the
same method, the hydrolysis proﬁle and reactivity of this
speciﬁc linker to the commonly used acylhydrazone linker.
Albeit other pH sensitive groups such as acetals are already
known, we decided to solely compare the SpiDo linker to the
well-known acylhydrazone linker.
■ RESULTS AND DISCUSSION
Literature analyses show that various acid-sensitive linkers have
been developed to date. However, the diﬀerence in
experimental condition (buﬀer, temperature, concentration,
etc.) between the diﬀerent studies makes direct comparison of
stability and degradability of diﬀerent linkers very diﬃcult. To
address this problem, we have conducted within our group an
HPLC-based hydrolysis assay and recorded the hydrolysis
proﬁles of a broad selection of acid-sensitive groups regularly
used in organic chemistry, i.e., acylhydrazone, acetal,
dialkylacetal, aryl-1,3-dioxolane, aryl-1,3-dioxane, ethoxybenzy-
limidazole, oxime, imine, and 3-alkylthiopropionate moieties.
From this study, we have identiﬁed a Spiro Diorthoester
(SpiDo) structure S3 which displayed a rapid hydrolysis proﬁle
selective toward acidic conditions (pH 5.5) relative to
physiological pH (see SI Figure S2). For comparison, we
prepared acyl and alkyl hydrazones derivatives (S4−S7) (see SI
Figure S3) and compared their hydrolysis proﬁles (see SI
Figure S4). Whereas acylhydrazones S4 and S5 showed little
hydrolysis at pH 5.5 and 7.4, alkylhydrazones S6 and S7 were
more sensitive to acidic conditions, and the most stable
alkylhydrazone S6 was chosen for comparison with S3.
With this promising result in hand, we then proceeded to
further compare the biosensitivities of SpiDo and alkylhy-
drazone. To ensure a rapid and eﬃcient method for measuring
hydrolysis in vitro, the SpiDo and alkylhydrazone linkers were
incorporated into activatable FRET-based probes 1 and 2,
respectively, whose 5-carboxytetramethylrhodamine (TAMRA)
ﬂuorescence is quenched by Black Hole Quencher-2 dye
(BHQ-2) via intramolecular FRET. Upon acid-catalyzed
hydrolysis of the pH-sensitive linker, the TAMRA and BHQ-
2 are separated and the ﬂuorescence of TAMRA can be
detected. A FRET-based probe 3 without pH-sensitive linker
has also been synthesized as a negative control. Of particular
interest, we designed the FRET-based TAMRA-Orthoester-
BHQ-2 probe 1 on the basis of a previously reported bis-
maleimide spiro diorthoester used for protein cross-linking.33
Starting from already known bis-maleimide Spiro Diorthoester
S1333 probe 1 was synthesized in one step by simultaneous
treatment of 4 with (BHQ-2)-SH34 and TAMRA-SH34 in 20%
yield (Scheme 1). Probe 2 was synthesized in three steps
starting from BHQ-2. Coupling of BHQ-2 with mono-Boc
protected hydrazine followed by deprotection with HCl gave
hydrazide S18, which was further condensed with freshly
prepared aldehyde S1634 to give probe 2 in average yield.
Finally, probe 3 was prepared in 3 steps starting from BHQ-2.
Coupling of BHQ-2 with synthesized linker S19,34 followed by
BOC deprotection using HCl, gave S21 which was further
coupled with TAMRA-acid using PyBOP to give probe 3. The
synthesis of probes 1 and 2 required careful attention with the
use of mild conditions when handling the highly pH-sensitive
group, and at the ﬁnal stage of the synthesis, the probes were
puriﬁed by preparative HPLC using NH3/HCOOH solution
(10 mM, pH 8.5)/MeCN as eluent system and no degradation
was observed.
Scheme 1. Synthesis of Probes 1−3
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Initially, kinetic measurements based on molecular ﬂuo-
rescence were conducted to evaluate the stability of the
diﬀerent probes for 15 h in aqueous buﬀer solutions at pH 5.5
(to simulate the lysosomal pH) and pH 7.4 (to simulate serum
conditions). At pH 5.5, probe 1 showed a rapid activation of
ﬂuorescence due to the hydrolysis of the SpiDo linker (Figure
1A). Probe 1 displayed a slight increase of ﬂuorescence at pH
7.4 but comparable to nonhydrolyzable probe 3. Initial rate
kinetics were compared and indicated that the hydrolysis of 1 in
acidic conditions was 23-fold faster than at physiological pH
(Figure 1B). The hydrolysis half time was found to be 1.5 h
(assuming a ﬁrst-order reaction) and full hydrolysis was
completed after 7 h at pH 5.5.
Under the same experimental conditions as with probe 1,
alkylhydrazone probe 2 displayed completely diﬀerent pH-
dependent hydrolysis proﬁles as well as reaction equilibration
(Figure 1A). Two diﬀerent rates were established: (i) a ﬁrst-
order reaction occurring within the ﬁrst hour associated with a
burst release and (ii) a slower rate, which was attributed to an
equilibrium state due to the reversible nature of hydrolysis of
the alkylhydrazone.35 Running the same experiment with an
excess of nucleophilic hydrazine to induce transamination
reaction and eliminate the reversibility of alkylhydrazone
hydrolysis conﬁrmed the equilibrated reaction (see SI Figure
S8). At pH 7.4, signiﬁcant hydrolysis of probe 2 was observed
compared to control probe 3. Kinetic data analysis revealed that
hydrolysis of 2 is 13-fold faster in acidic conditions.
Interestingly, while initial rates of 1 and 2 appear to be quite
similar at pH 5.5, 1 was considerably more stable at pH 7.4
suggesting that SpiDo is more sensitive to pH-variation than
the alkylhydrazone linker (Figure 1B).
The biosensitivities of the diﬀerent probes (1−3) were also
studied in tissue cultures and cells were analyzed by confocal
microscopy as well as ﬂow cytometry to provide spatial and
quantitative information about intracellular probe hydrolysis.
First, BNL CL.2, a mouse liver cell line, was loaded with the
various probes (1 μM, 90 min) with nuclei stained by Hoechst
33258. Representative images are shown in Figure 2 (images
A−C). SpiDo-based probe 1 exhibited the expected ﬂuorescent
signal with a vesicular distribution (image A) compared to
negative control 3 (image C). In the case of alkylhydrazone-
based probe 2, ﬂuorescence activation was also observed,
however, with lower intensities (Figure 2B). In order to
associate ﬂuorescence activation to intracellular acidic con-
ditions, 1 was costained with LysoTracker Green DND-26,
which is known to stain acidic compartments in live cells such
as lysosomes. To our delight, cells displayed colocalization of
the red and green ﬂuorescence as a result of the TAMRA and
lysotracker, respectively, resulting in an orange signal in a
merged picture (images D−F). This colocalization suggests that
the probe is taken up by cells to be speciﬁcally hydrolyzed in
acidic organelles. Moreover, ﬂow cytometry experiments were
conducted for additional quantitative comparison. Cells were
incubated with probes 1 and 2 for 4 h, suspended in media and
analyzed. Probe 1 exhibited a 2.6-fold higher level of
ﬂuorescence (A.U.F.) than probe 2, conﬁrming an increased
rate of hydrolysis of SpiDo relative to alkylhydrazone (see SI
Figure S9). These cellular results are in good agreement with
buﬀer based experiments (Figure 1).
To further validate that hydrolysis of 1 is triggered by pH and
not by any other mechanism, endosomal/lysosomal system
acidiﬁcation was inhibited by chloroquine (CQ) which is a
weak base known to quickly raise intracellular pH.36 Cells were
pretreated with chloroquine (100 μM, 2 h) prior to probe
incubation (1 μM, 4 h), and analyzed by ﬂow cytometry.
Fluorescence activation in CQ-treated cells considerably
decreased by 45% and 35% for 1 and 2, respectively, compared
to untreated cells (Figure 3 and SI Figure S10). These results
clearly demonstrate that activation of both 1 and 2 occurred
intracellularly due to pH variation. The lower eﬀect of CQ-
treatment on probe 2 may suggest other mechanisms for its
activation, such as transamination reactions with proteins.
Finally, we decided to investigate the stabilities of probes 1−3
in human plasma (Figure 4). A strong increase of ﬂuorescence
was observed for alkylhydrazone-based probe 2, while the level
of ﬂuorescence of SpiDo probe 1 remained at a level
comparable to control probe 3.
Figure 1. Hydrolysis kinetics of FRET-based probes 1−3. (A)
Hydrolysis kinetics of FRET-based probes 1 (red lines), 2 (blue lines),
and 3 (black lines) at pH 5.5 (solid lines) and 7.4 (dashed lines). All
data were recorded in triplicate at room temperature on a microplate
reader and with a probe concentration of 0.5 μM in phosphate buﬀers
(NaH2PO4/Na2HPO4 pH 7.4 or KH2PO4/Na2HPO4 pH 5.5, 100
mM). (B) Initial rate kinetics calculated for 10% of conversion of 1
and 2 at pH 5.5 and 7.4 assuming a ﬁrst-order reaction.
Figure 2. In vitro imaging of BNL CL.2 cells loaded with probes 1−3.
In vitro imaging of BNL CL.2 cells loaded with probes 1 (image A), 2
(image B), and 3 (image C). Distribution and colocalization of 1 with
lysosomal probe DND-26 (images D−F). Image D: green channel =
lysotracker DND-26 ﬂuorescence, image E: red channel = 1
ﬂuorescence, image F: merge channels. Live cell staining and imaging
were carried out by initially staining with the diﬀerent probes (1 μM,
90 min) followed by staining with Hoechst 33258 to stain the nuclei
(5 μg/mL, 30 min). For colocalization experiments, cells were stained
with LysoTracker Green DND-26 (100 nM, 30 min). Confocal
ﬂuorescence microscopy of living cells was performed. Scale bar: 25
μm.
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■ CONCLUSION
In conclusion, we have revealed that Spiro Diorthoester
(SpiDo) derivative is a potent acid-labile group for the
development of pH-sensitive targeted systems. After HPLC-
based kinetics of model compounds, the SpiDo motif was
inserted into FRET-based probes and the hydrolysis kinetics
was recorded and compared to a related acylhydrazone FRET-
based probe. This speciﬁc SpiDo linker has shown a fast and
pH sensitive hydrolysis under mild acidic conditions. The
biosensitivities of the diﬀerent probes were also studied in
cellular systems and colocalization experiments showed that the
SpiDo FRET-based probe was speciﬁcally hydrolyzed in acidic
organelles. Finally, stability of both probes was investigated in
human plasma and the SpiDo probe proved to be highly stable
compared to the acylhydrazone probe. As a result, the proﬁle of
SpiDo makes it a very promising acid-labile group for pH-
sensitive targeted systems such as internalizing ADCs.
■ ASSOCIATED CONTENT
*S Supporting Information
Complete experimental procedures, characterization of new
compounds. The Supporting Information is available free of
charge on the ACS Publications website at DOI: 10.1021/
acs.bioconjchem.5b00280.
■ AUTHOR INFORMATION
Corresponding Authors
*E-mail: s.jacques@unistra.fr.
*E-mail: alwag@unistra.fr.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
This work was supported through a research contract funded
by the French Ministry of Research. The International Center
for Frontier Research in Chemistry (icFRC) is acknowledged
for ﬁnancial support to LFCS.
■ REFERENCES
(1) Bildstein, L., Dubernet, C., and Couvreur, P. (2011) Prodrug-
based intracellular delivery of anticancer agents. Adv. Drug Delivery Rev.
63, 3−23.
(2) Leriche, G., Chisholm, L., and Wagner, A. (2012) Cleavable
linkers in chemical biology. Bioorg. Med. Chem. 20, 571−582.
(3) Ganta, S., Devalapally, H., Shahiwala, A., and Amiji, M. (2008) A
review of stimuli-responsive nanocarriers for drug and gene delivery. J.
Controlled Release 126, 187−204.
(4) Mauser, T., Dej́ugnat, C., and Sukhorukov, G. B. (2004)
Reversible pH-Dependent Properties of Multilayer Microcapsules
Made of Weak Polyelectrolytes. Macromol. Rapid Commun. 25, 1781−
1785.
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